Who Supplies Tofacitinib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Tofacitinib exports, with 119+ registered manufacturers shipping to buyers across 67+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 41.7% (export value: $1.6M). Close behind, BABA AGENCIES (4.1%, $162.5K). CROIENT PHARMA PRIVATE LIMITED (3.9%, $155.3K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Tofacitinib? Top Manufacturers & Their Buyers
Flow of Tofacitinib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Tofacitinib Supplier Network — Key Market Intelligence
The Tofacitinib export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 41.7% share, shipping $1.6M worth of product across 9 shipments. The second-largest exporter, BABA AGENCIES, contributes $162.5K (4.1%) to the overall market. Combined, the top two suppliers alone account for 45.8% of all Tofacitinib exports, indicating a relatively concentrated supply base.
Across all 119 tracked manufacturers, the total Tofacitinib export value stands at $4.0M from 814 shipments. The market average shipment value is $4.9K. The single largest buyer relationship in terms of trade value is TARO PHARMACEUTICALS INC., receiving $1.4M worth of product.
The combined buyer network spans 11 named purchasing companies, including TARO PHARMACEUTICALS INC., NILA JAMAL ENTERPRISE, VMG HEALTHCARE PRODUCTS GUATEMALA S, SHAMS AL-THURAYA CO, HARLEYS LIMITED and 6 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Tofacitinib exporter from India, with a market share of 41.7% and a total export value of $1.6M across 9 shipments. Their average shipment value of $183.1K is above the market average of $4.9K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 2 named buyers in our database. TARO PHARMACEUTICALS INC. is the dominant customer, accounting for 86.3% of this supplier's tracked business. Top customers include:
• TARO PHARMACEUTICALS INC. — $1.4M across 8 shipments (86.3% of this supplier's total exports)
• TARO PHARMACEUTICALS INC. — $225.6K across 1 shipments (13.7% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $183.1K is 3673% above the market average of $4.9K, consistent with large-order contracts or value-added formulations.
2BABA AGENCIES
BABA AGENCIES is the second-largest Tofacitinib exporter from India, with a market share of 4.1% and a total export value of $162.5K across 14 shipments. Their average shipment value of $11.6K is above the market average of $4.9K, suggesting premium or bulk contract pricing.
BABA AGENCIES serves 1 named buyer in our database. NILA JAMAL ENTERPRISE is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• NILA JAMAL ENTERPRISE — $162.5K across 14 shipments (100.0% of this supplier's total exports)
Key Insight: BABA AGENCIES's per-shipment value of $11.6K is 139% above the market average of $4.9K, consistent with large-order contracts or value-added formulations.
3CROIENT PHARMA PRIVATE LIMITED
CROIENT PHARMA PRIVATE LIMITED is the third-largest Tofacitinib exporter from India, with a market share of 3.9% and a total export value of $155.3K across 3 shipments. Their average shipment value of $51.8K is above the market average of $4.9K, suggesting premium or bulk contract pricing.
CROIENT PHARMA PRIVATE LIMITED serves 1 named buyer in our database. VMG HEALTHCARE PRODUCTS GUATEMALA S is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• VMG HEALTHCARE PRODUCTS GUATEMALA S — $155.3K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: CROIENT PHARMA PRIVATE LIMITED's per-shipment value of $51.8K is 967% above the market average of $4.9K, consistent with large-order contracts or value-added formulations.
4AJANTA PHARMA LIMITED
AJANTA PHARMA LIMITED is the fourth-largest Tofacitinib exporter from India, with a market share of 2.8% and a total export value of $112.4K across 36 shipments. Their average shipment value of $3.1K is below the market average of $4.9K, reflecting a high-volume, competitive pricing strategy.
AJANTA PHARMA LIMITED serves 5 named buyers in our database. SHAMS AL-THURAYA CO is the dominant customer, accounting for 58.2% of this supplier's tracked business. Top customers include:
• SHAMS AL-THURAYA CO — $65.4K across 21 shipments (58.2% of this supplier's total exports)
• HARLEYS LIMITED — $15.8K across 5 shipments (14.1% of this supplier's total exports)
• ABACUS PHARMA (A) LTD — $14.6K across 5 shipments (13.0% of this supplier's total exports)
• ASTRA PHARMA (T) LTD — $10.6K across 3 shipments (9.4% of this supplier's total exports)
• ASTRA PHARMA (T) LTD — $6.0K across 2 shipments (5.3% of this supplier's total exports)
Key Insight: AJANTA PHARMA LIMITED operates with high shipment frequency (36 shipments) at a per-shipment value of $3.1K, indicating a broad distribution network with many smaller, regular orders.
5SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED
SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED is the fifth-largest Tofacitinib exporter from India, with a market share of 2.1% and a total export value of $82.4K across 26 shipments. Their average shipment value of $3.2K is below the market average of $4.9K, reflecting a high-volume, competitive pricing strategy.
SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED serves 3 named buyers in our database. ATLAS TRADING COMPANY is the dominant customer, accounting for 95.6% of this supplier's tracked business. Top customers include:
• ATLAS TRADING COMPANY — $78.8K across 25 shipments (95.6% of this supplier's total exports)
• SKIN LINE LOGISTIC — $1.9K across 1 shipments (2.3% of this supplier's total exports)
• ZMC EXPRESS CARGO FZ — $1.7K across 1 shipments (2.1% of this supplier's total exports)
Key Insight: SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED operates with high shipment frequency (26 shipments) at a per-shipment value of $3.2K, indicating a broad distribution network with many smaller, regular orders.
6GLIESSE PHARMACEUTICALS PRIVATE LIMITED
GLIESSE PHARMACEUTICALS PRIVATE LIMITED is the fifth-largest Tofacitinib exporter from India, with a market share of 1.3% and a total export value of $53.2K across 3 shipments. Their average shipment value of $17.7K is above the market average of $4.9K, suggesting premium or bulk contract pricing.
GLIESSE PHARMACEUTICALS PRIVATE LIMITED serves 1 named buyer in our database. M S TARO PHARMACEUTI is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• M S TARO PHARMACEUTI — $53.2K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: GLIESSE PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $17.7K is 266% above the market average of $4.9K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Tofacitinib Flows
Once Tofacitinib leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and BABA AGENCIES, it travels to 5 destination markets with a combined import value of $4.0M. Canada absorbs the largest share at 61.1% ($2.4M), followed by United States (15.0%) and Iraq (5.1%).
In Canada — the top destination — named importers include TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC, TARO PHARMACEUTICALS INC..
This geographic spread reflects Tofacitinib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Tofacitinib Go? Top Importing Countries & Their Buyers
Trade flow of Tofacitinib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Canada
Canada ranks as the first-largest destination for Tofacitinib imports from India, with a total trade value of $2.4M across 9 shipments — representing a 61.1% share of all Tofacitinib exports. The average shipment value of $268.5K is above the global average of $4.9K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Tofacitinib importers in Canada: TARO PHARMACEUTICALS INC., is the largest buyer, accounting for 58.9% ($1.4M) of this market's total imports.
• TARO PHARMACEUTICALS INC., — $1.4M (58.9% of Canada's total)
• TARO PHARMACEUTICALS INC — $1.3M (53.9% of Canada's total)
• TARO PHARMACEUTICALS INC. — $225.6K (9.3% of Canada's total)
Key Insight: Canada's per-shipment average of $268.5K (5430% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Tofacitinib imports from India.
2United States
United States ranks as the second-largest destination for Tofacitinib imports from India, with a total trade value of $590.9K across 0 shipments — representing a 15.0% share of all Tofacitinib exports. The average shipment value of $590.9K is above the global average of $4.9K, indicating high-value procurement contracts or branded formulations.
Key Insight: United States's per-shipment average of $590.9K (12072% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Tofacitinib imports from India.
3Iraq
Iraq ranks as the third-largest destination for Tofacitinib imports from India, with a total trade value of $203.4K across 32 shipments — representing a 5.1% share of all Tofacitinib exports. The average shipment value of $6.4K is above the global average of $4.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Tofacitinib importers in Iraq: ATLAS TRADING COMPANY is the largest buyer, accounting for 40.1% ($81.5K) of this market's total imports.
• ATLAS TRADING COMPANY — $81.5K (40.1% of Iraq's total)
• TO THE MANAGER — $13.3K (6.6% of Iraq's total)
Key Insight: Iraq's per-shipment average of $6.4K (31% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Iraq is a key market for Tofacitinib imports from India.
4Guatemala
Guatemala ranks as the fourth-largest destination for Tofacitinib imports from India, with a total trade value of $188.1K across 7 shipments — representing a 4.8% share of all Tofacitinib exports. The average shipment value of $26.9K is above the global average of $4.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Tofacitinib importers in Guatemala: VMG HEALTHCARE PRODUCTS GUATEMALA S is the largest buyer, accounting for 82.6% ($155.3K) of this market's total imports.
• VMG HEALTHCARE PRODUCTS GUATEMALA S — $155.3K (82.6% of Guatemala's total)
• BALAXI HEALTHCARE GUATEMALA, S.A. — $13.4K (7.1% of Guatemala's total)
Key Insight: Guatemala's per-shipment average of $26.9K (453% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Guatemala is a key market for Tofacitinib imports from India.
5Malaysia
Malaysia ranks as the fifth-largest destination for Tofacitinib imports from India, with a total trade value of $163.4K across 14 shipments — representing a 4.1% share of all Tofacitinib exports. The average shipment value of $11.7K is above the global average of $4.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Tofacitinib importers in Malaysia: NILA JAMAL ENTERPRISE is the largest buyer, accounting for 100.0% ($163.4K) of this market's total imports.
• NILA JAMAL ENTERPRISE — $163.4K (100.0% of Malaysia's total)
Key Insight: Malaysia's per-shipment average of $11.7K (140% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Malaysia is a key market for Tofacitinib imports from India.
People Also Ask — Tofacitinib Supplier & Trade Network
Who are the top suppliers of Tofacitinib from India?+
Which companies buy Tofacitinib from Indian manufacturers?+
Where does Tofacitinib exported from India go?+
What is the market share of the top Tofacitinib supplier from India?+
What is the average shipment value for Tofacitinib exports from India?+
Is Tofacitinib manufactured in India and exported globally?+
Which country imports the most Tofacitinib from India?+
Who are the buyers of Tofacitinib in United States?+
How concentrated is the Tofacitinib supplier market in India?+
How do I find verified buyers for Tofacitinib in specific countries?+
Tofacitinib Trade Network — Key Takeaways
- 1SUN PHARMACEUTICAL INDUSTRIES LIMITED is India's dominant Tofacitinib exporter with a 41.7% market share and $1.6M in total exports — making it the single most important sourcing entity in this market.
- 2The top 119 suppliers collectively account for 56.0% of all tracked Tofacitinib exports, with a combined trade value of $4.0M.
- 3Canada is the largest destination market, absorbing 61.1% of India's Tofacitinib exports ($2.4M). United States (15.0%) and Iraq (5.1%) follow.
- 4With 814 total shipments averaging $4.9K each, the Tofacitinib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include TARO PHARMACEUTICALS INC., TARO PHARMACEUTICALS INC., NILA JAMAL ENTERPRISE, VMG HEALTHCARE PRODUCTS GUATEMALA S — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 2 customers
6 suppliers → 67 countries
Network value: $4.0M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tofacitinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Tofacitinib.
- 2.Flow Mapping: 119 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 814 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 67 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
814 Verified Shipments
119 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists